Genomics plc scores $30m to expand patient-centric health platform
Latest funding round includes investments from Foresite Capital and F-Prime Capital
Read More
Tag: Genomics plc
Genomics plc develops predictive tests for common diseases
Genomics plc has announced the development of predictive genomic tests for 16 common diseases.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
